正海生物：活性生物骨兼备有效性及安全性

Core Viewpoint - The company, Zhenghai Biological, announced on November 17 that its active biological bone product has received positive feedback in clinical applications due to its excellent performance, combining efficacy and safety [1] Product Performance - The active biological bone product utilizes the active factor rhBMP-2, which specifically binds with bone filling products, creating an effective bone regeneration system that operates with low overall dosage and high local efficacy [1] - This technology enhances treatment outcomes while significantly reducing safety risks, addressing some concerns that doctors have regarding BMP products [1] Future Development Strategy - The company plans to continue advancing product development and hospital admissions to increase market coverage [1] - There will be a focus on increasing usage penetration in benchmark hospitals and enhancing the development proportion in leading hospitals to support sustained product growth [1]